Clinical Trials
2 trialsNCT00920556 2019-02-27
A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
GlaxoSmithKline
Phase 2 Terminated
NCT00920803 2017-06-14
A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases
GlaxoSmithKline
Phase 1 Completed